These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21447106)

  • 21. The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls.
    Graham DP; Cully JA; Snow AL; Massman P; Doody R
    Alzheimer Dis Assoc Disord; 2004; 18(4):236-40. PubMed ID: 15592137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues.
    Perneczky R; Pohl C; Sorg C; Hartmann J; Komossa K; Alexopoulos P; Wagenpfeil S; Kurz A
    Age Ageing; 2006 May; 35(3):240-5. PubMed ID: 16513677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is functional decline necessary for a diagnosis of Alzheimer's disease?
    Park KW; Pavlik VN; Rountree SD; Darby EJ; Doody RS
    Dement Geriatr Cogn Disord; 2007; 24(5):375-9. PubMed ID: 17914262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the Severe Impairment Battery for patients with Alzheimer's disease in Korea.
    Suh GH; Kang CJ
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):626-32. PubMed ID: 16821258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer disease assessment scale: useful for both early detection and staging of dementia of the Alzheimer type.
    Zec RF; Landreth ES; Vicari SK; Feldman E; Belman J; Andrise A; Robbs R; Kumar V; Becker R
    Alzheimer Dis Assoc Disord; 1992; 6(2):89-102. PubMed ID: 1389084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients].
    Hirono N; Mori E; Ikejiri Y; Imamura T; Shimomura T; Hashimoto M; Yamashita H; Ikeda M
    No To Shinkei; 1997 Mar; 49(3):266-71. PubMed ID: 9125732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing change in cognitive function in dementia: the relative utilities of the Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Cognitive Drug Research system.
    Wesnes KA
    Neurodegener Dis; 2008; 5(3-4):261-3. PubMed ID: 18322407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Item analysis of ADAS-Cog: effect of baseline cognitive impairment in a clinical AD trial.
    Sevigny JJ; Peng Y; Liu L; Lines CR
    Am J Alzheimers Dis Other Demen; 2010 Mar; 25(2):119-24. PubMed ID: 19949163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Shortened version of the Barcelona test (III): criterion validity with the ADAS-Cog].
    Peña-Casanova J; Meza M; Bertran-Serra I; Manero RM; Espel G; Martí A; Böhm P; Blesa R; Guardia J
    Neurologia; 1997 Mar; 12(3):117-9. PubMed ID: 9198452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vascular factors and the psychopathological picture in Alzheimer's disease].
    Idzan LB; Bidzan M
    Psychiatr Pol; 2006; 40(5):823-31. PubMed ID: 17217228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
    Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
    J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolongation of T(2) relaxation times of hippocampus and amygdala in Alzheimer's disease.
    Wang H; Yuan H; Shu L; Xie J; Zhang D
    Neurosci Lett; 2004 Jun; 363(2):150-3. PubMed ID: 15172104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adaptation and normalization of the Alzheimer's disease Assessment Scale for Spain (NORMACODEM) (II)].
    Peña-Casanova J; Aguilar M; Santacruz P; Bertran-Serra I; Hernández G; Sol JM; Pujol A; Blesa R
    Neurologia; 1997 Feb; 12(2):69-77. PubMed ID: 9147454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclandelate in the treatment of patients with mild to moderate primary degenerative dementia of the Alzheimer type or vascular dementia: experience from a placebo controlled multi-center study.
    Weyer G; Eul A; Milde K; Wierich W; Herrmann WM
    Pharmacopsychiatry; 2000 May; 33(3):89-97. PubMed ID: 10855459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Is it pseudo-dementia? The validation of the Adas-Cog questionnaire in Hungary].
    Drótos G; Pákáski M; Papp E; Kálmán J
    Psychiatr Hung; 2012; 27(2):82-91. PubMed ID: 22700619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A neuropsychological test battery for use in Alzheimer disease clinical trials.
    Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M
    Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease.
    Wiig EH; Annas P; Basun H; Andreasen N; Lannfelt L; Zetterberg H; Blennow K; Minthon L
    Acta Neurol Scand; 2010 Mar; 121(3):186-93. PubMed ID: 19785641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease.
    Rozzini L; Vicini Chilovi B; Bertoletti E; Conti M; Delrio I; Trabucchi M; Padovani A
    J Geriatr Psychiatry Neurol; 2008 Dec; 21(4):261-7. PubMed ID: 19017783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease.
    Rockwood K; Fay S; Gorman M
    Int J Geriatr Psychiatry; 2010 Feb; 25(2):191-201. PubMed ID: 19548273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies.
    Mecocci P; Bladström A; Stender K
    Int J Geriatr Psychiatry; 2009 May; 24(5):532-8. PubMed ID: 19274640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.